Synektik Spólka Akcyjna (WSE:SNT)
Poland · Delayed Price · Currency is PLN 298.80
-1.20 (-0.40%)
Jan 21, 2026, 1:35 PM CET
Synektik Spólka Akcyjna Revenue
In the fiscal year ending September 30, 2025, Synektik Spólka Akcyjna had annual revenue of 681.60M PLN with 9.21% growth. Synektik Spólka Akcyjna had revenue of 199.54M in the quarter ending September 30, 2025, with 41.37% growth.
Revenue
681.60M
Revenue Growth
+9.21%
P/S Ratio
3.75
Revenue / Employee
2.95M
Employees
231
Market Cap
2.56B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 681.60M | 57.48M | 9.21% |
| Sep 30, 2024 | 624.12M | 177.25M | 39.66% |
| Sep 30, 2023 | 446.87M | 280.01M | 167.81% |
| Sep 30, 2022 | 166.86M | 38.23M | 29.72% |
| Sep 30, 2021 | 128.63M | 3.24M | 2.59% |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| NEUCA | 13.34B |
| Diagnostyka | 2.30B |
| Centrum Medyczne ENEL-MED | 820.59M |
| Mercator Medical | 585.57M |
| Voxel | 568.83M |
| Selvita | 373.90M |
| Celon Pharma | 225.60M |
| Ryvu Therapeutics | 90.41M |